Top Markets
#1 ADO Protocol ADO Protocol +195.12%
#2 Islamic Coin Islamic Coin +155.34%
#3 GoPlus Security GoPlus Security +42.40%
#4 GAIB AID GAIB AID +24.67%
#5 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +18.58%
#6 TENDIES TENDIES +15.93%
#7 Tutorial Tutorial +14.90%
#8 Wrapped NXM Wrapped NXM +14.40%
#9 Verus Coin Verus Coin +13.64%
#10 Pons Pons +11.86%
Coin of the day
ADO Protocol ADO Protocol
Instellingen
Taal
DUTCH
Valuta
USD
Thema
TME Pharma N.V. TME Pharma N.V.

TME Pharma N.V.

ALTME
Rang in aandelen #33659
TME Pharma N.V., a biopharmaceutical company in the clinical development stage... TME Pharma N.V., a biopharmaceutical company in the clinical development stage based in Berlin, Germany, is dedicated to pioneering innovative therapeutic solutions for cancer. The company leverages its unique Spiegelmer platform to advance a pipeline of investigational drug candidates. Its primary oncology asset, NOX-A12, is currently being evaluated in clinical studies as a combination therapy for a range of challenging cancers, including metastatic pancreatic and colorectal cancer, glioblastoma, and myeloma. Beyond its cancer-focused efforts, TME Pharma also developed NOX-E36, which has successfully concluded Phase 1/2 clinical trials for diabetic nephropathy. The company has formed a strategic collaboration with Merck Sharp & Dohme Corp. to explore NOX-A12 in combination with Keytruda and two different chemotherapy protocols as a second-line intervention for patients battling metastatic pancreatic cancer. Founded in 1997, the organization adopted its current name, TME Pharma N.V., in July 2022, having previously operated as NOXXON Pharma N.V.
Aandeelprijs
$0.07591393
Laatst gesynchroniseerd: 2026-08-14
Marktkapitalisatie
$7.15M
Verandering (1 dag)
3.90%
Verandering (1 jaar)
-41.05%
Land
DE
Handel TME Pharma N.V. (ALTME)

Categorie

Healthcare
Koersgeschiedenis voor TME Pharma N.V. (ALTME)
Hoogste slotkoers: $0.07 op 2026-08-01

Laagste slotkoers: $2.42K op 2016-09-01
Koersgeschiedenis van TME Pharma N.V. van 2016 tot 2026
Jaarlijkse koersprestatie
Jaar Prestaties
2026 (TTM) 32.43%
2025 -15.09%
2024 -67.73%
2023 -81.54%
2022 -95.65%
2021 -45.73%
2020 27.62%
2019 -67.02%
2018 -81.06%
2017 -65.91%
2016 0.00%
Aandelenkoers van vergelijkbare bedrijven of concurrenten
Bedrijf Aandelenkoers Verandering 1jr% Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $505.24 28.63%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $846.09 29.41%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $731.69 6.47%
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 $1.07K -6.40%
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 $251.82 11.75%
BE